ISC 2020: NASPAF-ICH Demonstrates Feasibility of Multicenter Trial of Antithrombotic Therapy in Atrial Fibrillation Patients Following Intracranial Hemorrhage
There were no recurrent intracranial hemorrhages among patients taking non-vitamin K oral anticoagulants
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.